nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Disulfiram—alcohol dependence	0.218	0.353	CbGbCtD
Rivaroxaban—ABCB1—Naltrexone—alcohol dependence	0.152	0.247	CbGbCtD
Rivaroxaban—ABCB1—Citalopram—alcohol dependence	0.101	0.164	CbGbCtD
Rivaroxaban—CYP3A4—Disulfiram—alcohol dependence	0.0849	0.138	CbGbCtD
Rivaroxaban—CYP3A4—Citalopram—alcohol dependence	0.0605	0.0981	CbGbCtD
Rivaroxaban—CYP2J2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00914	0.072	CbGpPWpGaD
Rivaroxaban—Linezolid—MAOB—alcohol dependence	0.00856	0.588	CrCbGaD
Rivaroxaban—Dermatitis atopic—Disulfiram—alcohol dependence	0.00641	0.0317	CcSEcCtD
Rivaroxaban—Linezolid—MAOA—alcohol dependence	0.006	0.412	CrCbGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00488	0.0385	CbGpPWpGaD
Rivaroxaban—Lactic dehydrogenase activity increased—Acamprosate—alcohol dependence	0.00457	0.0226	CcSEcCtD
Rivaroxaban—ABCB1—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.00455	0.0359	CbGpPWpGaD
Rivaroxaban—CYP2J2—Xenobiotics—CYP2E1—alcohol dependence	0.00429	0.0338	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00404	0.0319	CbGpPWpGaD
Rivaroxaban—Blood lactate dehydrogenase increased—Acamprosate—alcohol dependence	0.00402	0.0199	CcSEcCtD
Rivaroxaban—Toothache—Naltrexone—alcohol dependence	0.00363	0.018	CcSEcCtD
Rivaroxaban—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00363	0.0286	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00344	0.0271	CbGpPWpGaD
Rivaroxaban—CYP2J2—Tryptophan metabolism—MAOB—alcohol dependence	0.00324	0.0255	CbGpPWpGaD
Rivaroxaban—Menorrhagia—Acamprosate—alcohol dependence	0.00316	0.0156	CcSEcCtD
Rivaroxaban—Eye haemorrhage—Citalopram—alcohol dependence	0.00299	0.0148	CcSEcCtD
Rivaroxaban—F10—cardiovascular system—alcohol dependence	0.00295	0.0737	CbGeAlD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00292	0.023	CbGpPWpGaD
Rivaroxaban—CYP2J2—forebrain—alcohol dependence	0.00286	0.0715	CbGeAlD
Rivaroxaban—CYP2J2—Tryptophan metabolism—ALDH2—alcohol dependence	0.00276	0.0217	CbGpPWpGaD
Rivaroxaban—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.00269	0.0133	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—ADH6—alcohol dependence	0.00259	0.0204	CbGpPWpGaD
Rivaroxaban—Rectal haemorrhage—Acamprosate—alcohol dependence	0.00259	0.0128	CcSEcCtD
Rivaroxaban—Jaundice—Disulfiram—alcohol dependence	0.00259	0.0128	CcSEcCtD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00256	0.0202	CbGpPWpGaD
Rivaroxaban—CYP3A5—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.0025	0.0197	CbGpPWpGaD
Rivaroxaban—Gingival bleeding—Citalopram—alcohol dependence	0.00247	0.0122	CcSEcCtD
Rivaroxaban—Oropharyngeal pain—Naltrexone—alcohol dependence	0.00243	0.012	CcSEcCtD
Rivaroxaban—CYP2J2—cardiovascular system—alcohol dependence	0.00242	0.0604	CbGeAlD
Rivaroxaban—Hepatitis—Disulfiram—alcohol dependence	0.00238	0.0118	CcSEcCtD
Rivaroxaban—F10—blood—alcohol dependence	0.00233	0.0583	CbGeAlD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00232	0.0183	CbGpPWpGaD
Rivaroxaban—Toothache—Citalopram—alcohol dependence	0.0023	0.0114	CcSEcCtD
Rivaroxaban—Haematoma—Citalopram—alcohol dependence	0.00223	0.011	CcSEcCtD
Rivaroxaban—CYP2J2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.0022	0.0174	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—ADH1A—alcohol dependence	0.00215	0.0169	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00212	0.0167	CbGpPWpGaD
Rivaroxaban—Ecchymosis—Acamprosate—alcohol dependence	0.00211	0.0104	CcSEcCtD
Rivaroxaban—F10—endocrine gland—alcohol dependence	0.00202	0.0506	CbGeAlD
Rivaroxaban—F10—testis—alcohol dependence	0.00193	0.0482	CbGeAlD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00192	0.0152	CbGpPWpGaD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00189	0.0149	CbGpPWpGaD
Rivaroxaban—Menorrhagia—Citalopram—alcohol dependence	0.00189	0.00936	CcSEcCtD
Rivaroxaban—Dermatitis atopic—Citalopram—alcohol dependence	0.00189	0.00936	CcSEcCtD
Rivaroxaban—CYP2J2—midbrain—alcohol dependence	0.00189	0.0472	CbGeAlD
Rivaroxaban—Renal failure acute—Acamprosate—alcohol dependence	0.00184	0.00909	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—ADH4—alcohol dependence	0.00183	0.0144	CbGpPWpGaD
Rivaroxaban—F10—liver—alcohol dependence	0.00182	0.0456	CbGeAlD
Rivaroxaban—Swelling—Naltrexone—alcohol dependence	0.00182	0.009	CcSEcCtD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00181	0.0142	CbGpPWpGaD
Rivaroxaban—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00178	0.014	CbGpPWpGaD
Rivaroxaban—Dermatitis bullous—Acamprosate—alcohol dependence	0.00177	0.00878	CcSEcCtD
Rivaroxaban—CYP2J2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00176	0.0139	CbGpPWpGaD
Rivaroxaban—Myocardial ischaemia—Citalopram—alcohol dependence	0.00174	0.00862	CcSEcCtD
Rivaroxaban—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.0017	0.00842	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.0017	0.00839	CcSEcCtD
Rivaroxaban—Pallor—Citalopram—alcohol dependence	0.00169	0.00836	CcSEcCtD
Rivaroxaban—CYP2J2—endocrine gland—alcohol dependence	0.00166	0.0415	CbGeAlD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00164	0.0129	CbGpPWpGaD
Rivaroxaban—Contusion—Citalopram—alcohol dependence	0.00161	0.00794	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.0016	0.00794	CcSEcCtD
Rivaroxaban—Pain in extremity—Naltrexone—alcohol dependence	0.0016	0.00794	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Acamprosate—alcohol dependence	0.00159	0.00786	CcSEcCtD
Rivaroxaban—CYP2J2—testis—alcohol dependence	0.00158	0.0395	CbGeAlD
Rivaroxaban—CYP2J2—Biological oxidations—ADH7—alcohol dependence	0.00155	0.0122	CbGpPWpGaD
Rivaroxaban—CYP2J2—nervous system—alcohol dependence	0.00155	0.0388	CbGeAlD
Rivaroxaban—Rectal haemorrhage—Citalopram—alcohol dependence	0.00155	0.00767	CcSEcCtD
Rivaroxaban—CYP2J2—liver—alcohol dependence	0.0015	0.0374	CbGeAlD
Rivaroxaban—CYP2J2—central nervous system—alcohol dependence	0.00149	0.0374	CbGeAlD
Rivaroxaban—CYP2J2—Biological oxidations—GGT2—alcohol dependence	0.00149	0.0117	CbGpPWpGaD
Rivaroxaban—Blood bilirubin increased—Citalopram—alcohol dependence	0.00148	0.00732	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Naltrexone—alcohol dependence	0.00147	0.00725	CcSEcCtD
Rivaroxaban—CYP2J2—cerebellum—alcohol dependence	0.00146	0.0365	CbGeAlD
Rivaroxaban—Fatigue—Disulfiram—alcohol dependence	0.00146	0.00722	CcSEcCtD
Rivaroxaban—Pain—Disulfiram—alcohol dependence	0.00145	0.00716	CcSEcCtD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00144	0.0114	CbGpPWpGaD
Rivaroxaban—Angina pectoris—Acamprosate—alcohol dependence	0.00143	0.00706	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00141	0.0111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00139	0.011	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—ADH1B—alcohol dependence	0.00136	0.0107	CbGpPWpGaD
Rivaroxaban—Angina pectoris—Naltrexone—alcohol dependence	0.00135	0.00668	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.00129	0.0102	CbGpPWpGaD
Rivaroxaban—Urinary tract infection—Acamprosate—alcohol dependence	0.00127	0.00628	CcSEcCtD
Rivaroxaban—Ecchymosis—Citalopram—alcohol dependence	0.00127	0.00626	CcSEcCtD
Rivaroxaban—Haematuria—Acamprosate—alcohol dependence	0.00125	0.00616	CcSEcCtD
Rivaroxaban—Infestation—Naltrexone—alcohol dependence	0.00124	0.00612	CcSEcCtD
Rivaroxaban—Infestation NOS—Naltrexone—alcohol dependence	0.00124	0.00612	CcSEcCtD
Rivaroxaban—CYP3A5—Xenobiotics—CYP2E1—alcohol dependence	0.00124	0.00974	CbGpPWpGaD
Rivaroxaban—Epistaxis—Acamprosate—alcohol dependence	0.00123	0.0061	CcSEcCtD
Rivaroxaban—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00122	0.00965	CbGpPWpGaD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00122	0.00961	CbGpPWpGaD
Rivaroxaban—Asthenia—Disulfiram—alcohol dependence	0.00121	0.00601	CcSEcCtD
Rivaroxaban—Urinary tract infection—Naltrexone—alcohol dependence	0.0012	0.00595	CcSEcCtD
Rivaroxaban—CYP3A5—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00119	0.00937	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00119	0.00936	CbGpPWpGaD
Rivaroxaban—CYP2J2—brain—alcohol dependence	0.00119	0.0297	CbGeAlD
Rivaroxaban—CYP3A5—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00118	0.00932	CbGpPWpGaD
Rivaroxaban—Haemoglobin—Acamprosate—alcohol dependence	0.00118	0.00583	CcSEcCtD
Rivaroxaban—Haemorrhage—Acamprosate—alcohol dependence	0.00117	0.0058	CcSEcCtD
Rivaroxaban—Hepatitis—Acamprosate—alcohol dependence	0.00117	0.0058	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00117	0.00578	CcSEcCtD
Rivaroxaban—Epistaxis—Naltrexone—alcohol dependence	0.00117	0.00577	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00117	0.00919	CbGpPWpGaD
Rivaroxaban—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00116	0.00916	CbGpPWpGaD
Rivaroxaban—Sinusitis—Naltrexone—alcohol dependence	0.00116	0.00574	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—MAOB—alcohol dependence	0.00113	0.00889	CbGpPWpGaD
Rivaroxaban—Dizziness—Disulfiram—alcohol dependence	0.00112	0.00554	CcSEcCtD
Rivaroxaban—Hepatitis—Naltrexone—alcohol dependence	0.00111	0.00549	CcSEcCtD
Rivaroxaban—Renal failure acute—Citalopram—alcohol dependence	0.0011	0.00545	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Naltrexone—alcohol dependence	0.00109	0.0054	CcSEcCtD
Rivaroxaban—Rash—Disulfiram—alcohol dependence	0.00107	0.00528	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Citalopram—alcohol dependence	0.00106	0.00526	CcSEcCtD
Rivaroxaban—Headache—Disulfiram—alcohol dependence	0.00106	0.00524	CcSEcCtD
Rivaroxaban—Immune system disorder—Acamprosate—alcohol dependence	0.00106	0.00524	CcSEcCtD
Rivaroxaban—Eye disorder—Naltrexone—alcohol dependence	0.00104	0.00513	CcSEcCtD
Rivaroxaban—Cardiac disorder—Naltrexone—alcohol dependence	0.00103	0.0051	CcSEcCtD
Rivaroxaban—Pain in extremity—Citalopram—alcohol dependence	0.00102	0.00503	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.00102	0.00503	CcSEcCtD
Rivaroxaban—Osteoarthritis—Citalopram—alcohol dependence	0.00102	0.00503	CcSEcCtD
Rivaroxaban—Angiopathy—Naltrexone—alcohol dependence	0.00101	0.00498	CcSEcCtD
Rivaroxaban—Immune system disorder—Naltrexone—alcohol dependence	0.001	0.00496	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Naltrexone—alcohol dependence	0.001	0.00495	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000991	0.00781	CbGpPWpGaD
Rivaroxaban—Back pain—Acamprosate—alcohol dependence	0.000988	0.00489	CcSEcCtD
Rivaroxaban—Muscle spasms—Acamprosate—alcohol dependence	0.000982	0.00486	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—ALDH2—alcohol dependence	0.00096	0.00756	CbGpPWpGaD
Rivaroxaban—CYP2J2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000954	0.00752	CbGpPWpGaD
Rivaroxaban—Ill-defined disorder—Acamprosate—alcohol dependence	0.000948	0.00469	CcSEcCtD
Rivaroxaban—Anaemia—Acamprosate—alcohol dependence	0.000944	0.00467	CcSEcCtD
Rivaroxaban—Back pain—Naltrexone—alcohol dependence	0.000935	0.00462	CcSEcCtD
Rivaroxaban—Angioedema—Acamprosate—alcohol dependence	0.000933	0.00462	CcSEcCtD
Rivaroxaban—Muscle spasms—Naltrexone—alcohol dependence	0.000929	0.0046	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Citalopram—alcohol dependence	0.000929	0.00459	CcSEcCtD
Rivaroxaban—Malaise—Acamprosate—alcohol dependence	0.000921	0.00456	CcSEcCtD
Rivaroxaban—Syncope—Acamprosate—alcohol dependence	0.000916	0.00453	CcSEcCtD
Rivaroxaban—Loss of consciousness—Acamprosate—alcohol dependence	0.000898	0.00444	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Naltrexone—alcohol dependence	0.000897	0.00444	CcSEcCtD
Rivaroxaban—Angioedema—Naltrexone—alcohol dependence	0.000883	0.00437	CcSEcCtD
Rivaroxaban—Malaise—Naltrexone—alcohol dependence	0.000872	0.00431	CcSEcCtD
Rivaroxaban—Chest pain—Acamprosate—alcohol dependence	0.00087	0.0043	CcSEcCtD
Rivaroxaban—Syncope—Naltrexone—alcohol dependence	0.000867	0.00429	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000864	0.00427	CcSEcCtD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00086	0.00677	CbGpPWpGaD
Rivaroxaban—Discomfort—Acamprosate—alcohol dependence	0.000859	0.00425	CcSEcCtD
Rivaroxaban—Angina pectoris—Citalopram—alcohol dependence	0.000856	0.00423	CcSEcCtD
Rivaroxaban—Dry mouth—Acamprosate—alcohol dependence	0.000851	0.00421	CcSEcCtD
Rivaroxaban—Loss of consciousness—Naltrexone—alcohol dependence	0.000849	0.0042	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000843	0.00664	CbGpPWpGaD
Rivaroxaban—Anaphylactic shock—Acamprosate—alcohol dependence	0.000834	0.00412	CcSEcCtD
Rivaroxaban—Infection—Acamprosate—alcohol dependence	0.000828	0.0041	CcSEcCtD
Rivaroxaban—CYP3A5—pancreas—alcohol dependence	0.000827	0.0207	CbGeAlD
Rivaroxaban—Chest pain—Naltrexone—alcohol dependence	0.000823	0.00407	CcSEcCtD
Rivaroxaban—Shock—Acamprosate—alcohol dependence	0.00082	0.00406	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000817	0.00404	CcSEcCtD
Rivaroxaban—Tachycardia—Acamprosate—alcohol dependence	0.000814	0.00402	CcSEcCtD
Rivaroxaban—Discomfort—Naltrexone—alcohol dependence	0.000813	0.00402	CcSEcCtD
Rivaroxaban—Skin disorder—Acamprosate—alcohol dependence	0.00081	0.00401	CcSEcCtD
Rivaroxaban—Dry mouth—Naltrexone—alcohol dependence	0.000805	0.00398	CcSEcCtD
Rivaroxaban—Oedema—Naltrexone—alcohol dependence	0.000789	0.0039	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Naltrexone—alcohol dependence	0.000789	0.0039	CcSEcCtD
Rivaroxaban—Infection—Naltrexone—alcohol dependence	0.000784	0.00388	CcSEcCtD
Rivaroxaban—Infestation—Citalopram—alcohol dependence	0.000784	0.00388	CcSEcCtD
Rivaroxaban—Infestation NOS—Citalopram—alcohol dependence	0.000784	0.00388	CcSEcCtD
Rivaroxaban—Hypotension—Acamprosate—alcohol dependence	0.000779	0.00385	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000777	0.00384	CcSEcCtD
Rivaroxaban—Shock—Naltrexone—alcohol dependence	0.000776	0.00384	CcSEcCtD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000774	0.0061	CbGpPWpGaD
Rivaroxaban—Nervous system disorder—Naltrexone—alcohol dependence	0.000774	0.00383	CcSEcCtD
Rivaroxaban—Tachycardia—Naltrexone—alcohol dependence	0.00077	0.00381	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—CYP2E1—alcohol dependence	0.000767	0.00605	CbGpPWpGaD
Rivaroxaban—Skin disorder—Naltrexone—alcohol dependence	0.000766	0.00379	CcSEcCtD
Rivaroxaban—Jaundice—Citalopram—alcohol dependence	0.000764	0.00378	CcSEcCtD
Rivaroxaban—Urinary tract infection—Citalopram—alcohol dependence	0.000762	0.00377	CcSEcCtD
Rivaroxaban—CYP2J2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000757	0.00596	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—ADH6—alcohol dependence	0.000747	0.00589	CbGpPWpGaD
Rivaroxaban—Haematuria—Citalopram—alcohol dependence	0.000747	0.0037	CcSEcCtD
Rivaroxaban—Dyspnoea—Acamprosate—alcohol dependence	0.000743	0.00368	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Citalopram—alcohol dependence	0.000741	0.00367	CcSEcCtD
Rivaroxaban—Epistaxis—Citalopram—alcohol dependence	0.000739	0.00366	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000739	0.00582	CbGpPWpGaD
Rivaroxaban—Sinusitis—Citalopram—alcohol dependence	0.000735	0.00364	CcSEcCtD
Rivaroxaban—Dyspepsia—Acamprosate—alcohol dependence	0.000734	0.00363	CcSEcCtD
Rivaroxaban—Agranulocytosis—Citalopram—alcohol dependence	0.000731	0.00362	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00072	0.00356	CcSEcCtD
Rivaroxaban—Constipation—Acamprosate—alcohol dependence	0.000713	0.00353	CcSEcCtD
Rivaroxaban—Pain—Acamprosate—alcohol dependence	0.000713	0.00353	CcSEcCtD
Rivaroxaban—Haemoglobin—Citalopram—alcohol dependence	0.000707	0.0035	CcSEcCtD
Rivaroxaban—CYP3A5—digestive system—alcohol dependence	0.000706	0.0177	CbGeAlD
Rivaroxaban—CYP2J2—Biological oxidations—GGT1—alcohol dependence	0.000704	0.00555	CbGpPWpGaD
Rivaroxaban—Haemorrhage—Citalopram—alcohol dependence	0.000703	0.00348	CcSEcCtD
Rivaroxaban—Hepatitis—Citalopram—alcohol dependence	0.000703	0.00348	CcSEcCtD
Rivaroxaban—Dyspnoea—Naltrexone—alcohol dependence	0.000703	0.00348	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Citalopram—alcohol dependence	0.000695	0.00344	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Citalopram—alcohol dependence	0.000691	0.00342	CcSEcCtD
Rivaroxaban—Urethral disorder—Citalopram—alcohol dependence	0.00069	0.00341	CcSEcCtD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000687	0.00542	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Acamprosate—alcohol dependence	0.000687	0.0034	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000682	0.00337	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000681	0.00337	CcSEcCtD
Rivaroxaban—Fatigue—Naltrexone—alcohol dependence	0.00068	0.00336	CcSEcCtD
Rivaroxaban—Pain—Naltrexone—alcohol dependence	0.000674	0.00334	CcSEcCtD
Rivaroxaban—Constipation—Naltrexone—alcohol dependence	0.000674	0.00334	CcSEcCtD
Rivaroxaban—CYP3A5—blood—alcohol dependence	0.000673	0.0168	CbGeAlD
Rivaroxaban—Erythema multiforme—Citalopram—alcohol dependence	0.000665	0.00329	CcSEcCtD
Rivaroxaban—Urticaria—Acamprosate—alcohol dependence	0.000662	0.00328	CcSEcCtD
Rivaroxaban—Abdominal pain—Acamprosate—alcohol dependence	0.000659	0.00326	CcSEcCtD
Rivaroxaban—Eye disorder—Citalopram—alcohol dependence	0.000657	0.00325	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000654	0.00515	CbGpPWpGaD
Rivaroxaban—Cardiac disorder—Citalopram—alcohol dependence	0.000653	0.00323	CcSEcCtD
Rivaroxaban—Feeling abnormal—Naltrexone—alcohol dependence	0.00065	0.00321	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000645	0.00319	CcSEcCtD
Rivaroxaban—Angiopathy—Citalopram—alcohol dependence	0.000638	0.00316	CcSEcCtD
Rivaroxaban—Immune system disorder—Citalopram—alcohol dependence	0.000635	0.00314	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Citalopram—alcohol dependence	0.000634	0.00314	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—MAOA—alcohol dependence	0.000631	0.00497	CbGpPWpGaD
Rivaroxaban—Urticaria—Naltrexone—alcohol dependence	0.000627	0.0031	CcSEcCtD
Rivaroxaban—Abdominal pain—Naltrexone—alcohol dependence	0.000624	0.00308	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—ADH1A—alcohol dependence	0.000619	0.00488	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Acamprosate—alcohol dependence	0.000614	0.00304	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000612	0.00483	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00061	0.00481	CbGpPWpGaD
Rivaroxaban—Asthenia—Acamprosate—alcohol dependence	0.000598	0.00296	CcSEcCtD
Rivaroxaban—Back pain—Citalopram—alcohol dependence	0.000592	0.00293	CcSEcCtD
Rivaroxaban—Pruritus—Acamprosate—alcohol dependence	0.00059	0.00292	CcSEcCtD
Rivaroxaban—Muscle spasms—Citalopram—alcohol dependence	0.000589	0.00291	CcSEcCtD
Rivaroxaban—CYP3A5—endocrine gland—alcohol dependence	0.000584	0.0146	CbGeAlD
Rivaroxaban—Hypersensitivity—Naltrexone—alcohol dependence	0.000581	0.00287	CcSEcCtD
Rivaroxaban—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000575	0.00453	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Acamprosate—alcohol dependence	0.00057	0.00282	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Citalopram—alcohol dependence	0.000568	0.00281	CcSEcCtD
Rivaroxaban—Anaemia—Citalopram—alcohol dependence	0.000566	0.0028	CcSEcCtD
Rivaroxaban—Asthenia—Naltrexone—alcohol dependence	0.000566	0.0028	CcSEcCtD
Rivaroxaban—Angioedema—Citalopram—alcohol dependence	0.00056	0.00277	CcSEcCtD
Rivaroxaban—Pruritus—Naltrexone—alcohol dependence	0.000558	0.00276	CcSEcCtD
Rivaroxaban—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000553	0.00436	CbGpPWpGaD
Rivaroxaban—Malaise—Citalopram—alcohol dependence	0.000552	0.00273	CcSEcCtD
Rivaroxaban—Dizziness—Acamprosate—alcohol dependence	0.000551	0.00273	CcSEcCtD
Rivaroxaban—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00055	0.00433	CbGpPWpGaD
Rivaroxaban—Syncope—Citalopram—alcohol dependence	0.000549	0.00272	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000542	0.00427	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Naltrexone—alcohol dependence	0.00054	0.00267	CcSEcCtD
Rivaroxaban—Loss of consciousness—Citalopram—alcohol dependence	0.000538	0.00266	CcSEcCtD
Rivaroxaban—ABCB1—forebrain—alcohol dependence	0.000535	0.0134	CbGeAlD
Rivaroxaban—CYP3A4—digestive system—alcohol dependence	0.00053	0.0132	CbGeAlD
Rivaroxaban—Vomiting—Acamprosate—alcohol dependence	0.00053	0.00262	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—ADH4—alcohol dependence	0.000527	0.00415	CbGpPWpGaD
Rivaroxaban—CYP3A5—liver—alcohol dependence	0.000526	0.0132	CbGeAlD
Rivaroxaban—Rash—Acamprosate—alcohol dependence	0.000526	0.0026	CcSEcCtD
Rivaroxaban—Dermatitis—Acamprosate—alcohol dependence	0.000525	0.0026	CcSEcCtD
Rivaroxaban—Headache—Acamprosate—alcohol dependence	0.000522	0.00258	CcSEcCtD
Rivaroxaban—Dizziness—Naltrexone—alcohol dependence	0.000522	0.00258	CcSEcCtD
Rivaroxaban—Chest pain—Citalopram—alcohol dependence	0.000521	0.00258	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000521	0.0041	CbGpPWpGaD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000518	0.00256	CcSEcCtD
Rivaroxaban—Discomfort—Citalopram—alcohol dependence	0.000515	0.00255	CcSEcCtD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000513	0.00405	CbGpPWpGaD
Rivaroxaban—Dry mouth—Citalopram—alcohol dependence	0.00051	0.00252	CcSEcCtD
Rivaroxaban—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000507	0.00399	CbGpPWpGaD
Rivaroxaban—CYP3A4—blood—alcohol dependence	0.000505	0.0126	CbGeAlD
Rivaroxaban—Vomiting—Naltrexone—alcohol dependence	0.000501	0.00248	CcSEcCtD
Rivaroxaban—Oedema—Citalopram—alcohol dependence	0.0005	0.00247	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Citalopram—alcohol dependence	0.0005	0.00247	CcSEcCtD
Rivaroxaban—Rash—Naltrexone—alcohol dependence	0.000497	0.00246	CcSEcCtD
Rivaroxaban—Dermatitis—Naltrexone—alcohol dependence	0.000497	0.00246	CcSEcCtD
Rivaroxaban—Infection—Citalopram—alcohol dependence	0.000496	0.00246	CcSEcCtD
Rivaroxaban—ABCB1—adrenal cortex—alcohol dependence	0.000495	0.0124	CbGeAlD
Rivaroxaban—Nausea—Acamprosate—alcohol dependence	0.000495	0.00245	CcSEcCtD
Rivaroxaban—Headache—Naltrexone—alcohol dependence	0.000494	0.00244	CcSEcCtD
Rivaroxaban—Shock—Citalopram—alcohol dependence	0.000492	0.00243	CcSEcCtD
Rivaroxaban—Nervous system disorder—Citalopram—alcohol dependence	0.00049	0.00242	CcSEcCtD
Rivaroxaban—Tachycardia—Citalopram—alcohol dependence	0.000488	0.00241	CcSEcCtD
Rivaroxaban—Skin disorder—Citalopram—alcohol dependence	0.000485	0.0024	CcSEcCtD
Rivaroxaban—Nausea—Naltrexone—alcohol dependence	0.000469	0.00232	CcSEcCtD
Rivaroxaban—Hypotension—Citalopram—alcohol dependence	0.000467	0.00231	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000461	0.00363	CbGpPWpGaD
Rivaroxaban—ABCB1—cardiovascular system—alcohol dependence	0.000452	0.0113	CbGeAlD
Rivaroxaban—CYP3A5—Biological oxidations—ADH7—alcohol dependence	0.000448	0.00353	CbGpPWpGaD
Rivaroxaban—Dyspnoea—Citalopram—alcohol dependence	0.000446	0.0022	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—ADH6—alcohol dependence	0.000443	0.00349	CbGpPWpGaD
Rivaroxaban—Dyspepsia—Citalopram—alcohol dependence	0.00044	0.00218	CcSEcCtD
Rivaroxaban—ABCB1—pancreas—alcohol dependence	0.000439	0.011	CbGeAlD
Rivaroxaban—CYP3A4—endocrine gland—alcohol dependence	0.000438	0.0109	CbGeAlD
Rivaroxaban—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000434	0.00342	CbGpPWpGaD
Rivaroxaban—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000431	0.00213	CcSEcCtD
Rivaroxaban—Fatigue—Citalopram—alcohol dependence	0.000431	0.00213	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—GGT2—alcohol dependence	0.000429	0.00338	CbGpPWpGaD
Rivaroxaban—Pain—Citalopram—alcohol dependence	0.000427	0.00211	CcSEcCtD
Rivaroxaban—Constipation—Citalopram—alcohol dependence	0.000427	0.00211	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000416	0.00328	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Citalopram—alcohol dependence	0.000412	0.00204	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—POMC—alcohol dependence	0.000411	0.00324	CbGpPWpGaD
Rivaroxaban—ABCB1—gonad—alcohol dependence	0.00041	0.0103	CbGeAlD
Rivaroxaban—CYP3A4—nervous system—alcohol dependence	0.00041	0.0102	CbGeAlD
Rivaroxaban—Gastrointestinal pain—Citalopram—alcohol dependence	0.000409	0.00202	CcSEcCtD
Rivaroxaban—Urticaria—Citalopram—alcohol dependence	0.000397	0.00196	CcSEcCtD
Rivaroxaban—Abdominal pain—Citalopram—alcohol dependence	0.000395	0.00195	CcSEcCtD
Rivaroxaban—CYP3A4—liver—alcohol dependence	0.000395	0.00987	CbGeAlD
Rivaroxaban—CYP3A4—central nervous system—alcohol dependence	0.000395	0.00987	CbGeAlD
Rivaroxaban—CYP3A5—Biological oxidations—ADH1B—alcohol dependence	0.000393	0.00309	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000392	0.00309	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000376	0.00296	CbGpPWpGaD
Rivaroxaban—ABCB1—digestive system—alcohol dependence	0.000375	0.00938	CbGeAlD
Rivaroxaban—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000369	0.00291	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Citalopram—alcohol dependence	0.000368	0.00182	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—ADH1A—alcohol dependence	0.000367	0.0029	CbGpPWpGaD
Rivaroxaban—Asthenia—Citalopram—alcohol dependence	0.000359	0.00177	CcSEcCtD
Rivaroxaban—ABCB1—blood—alcohol dependence	0.000358	0.00894	CbGeAlD
Rivaroxaban—Pruritus—Citalopram—alcohol dependence	0.000354	0.00175	CcSEcCtD
Rivaroxaban—ABCB1—midbrain—alcohol dependence	0.000353	0.00882	CbGeAlD
Rivaroxaban—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000347	0.00274	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000344	0.00271	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000343	0.0027	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Citalopram—alcohol dependence	0.000342	0.00169	CcSEcCtD
Rivaroxaban—Dizziness—Citalopram—alcohol dependence	0.00033	0.00163	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—MAOB—alcohol dependence	0.000325	0.00256	CbGpPWpGaD
Rivaroxaban—Vomiting—Citalopram—alcohol dependence	0.000318	0.00157	CcSEcCtD
Rivaroxaban—Rash—Citalopram—alcohol dependence	0.000315	0.00156	CcSEcCtD
Rivaroxaban—Dermatitis—Citalopram—alcohol dependence	0.000315	0.00156	CcSEcCtD
Rivaroxaban—Headache—Citalopram—alcohol dependence	0.000313	0.00155	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—ADH4—alcohol dependence	0.000312	0.00246	CbGpPWpGaD
Rivaroxaban—ABCB1—endocrine gland—alcohol dependence	0.00031	0.00775	CbGeAlD
Rivaroxaban—Nausea—Citalopram—alcohol dependence	0.000297	0.00147	CcSEcCtD
Rivaroxaban—ABCB1—testis—alcohol dependence	0.000296	0.00739	CbGeAlD
Rivaroxaban—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000295	0.00233	CbGpPWpGaD
Rivaroxaban—ABCB1—nervous system—alcohol dependence	0.00029	0.00725	CbGeAlD
Rivaroxaban—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000288	0.00227	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000285	0.00224	CbGpPWpGaD
Rivaroxaban—ABCB1—liver—alcohol dependence	0.00028	0.00699	CbGeAlD
Rivaroxaban—ABCB1—central nervous system—alcohol dependence	0.000279	0.00698	CbGeAlD
Rivaroxaban—CYP3A5—Biological oxidations—ALDH2—alcohol dependence	0.000277	0.00218	CbGpPWpGaD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000275	0.00217	CbGpPWpGaD
Rivaroxaban—ABCB1—cerebellum—alcohol dependence	0.000273	0.00683	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.00027	0.00213	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ADH7—alcohol dependence	0.000266	0.00209	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GGT2—alcohol dependence	0.000255	0.00201	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000245	0.00193	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000242	0.00191	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000239	0.00188	CbGpPWpGaD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000236	0.00186	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ADH1B—alcohol dependence	0.000233	0.00184	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000223	0.00176	CbGpPWpGaD
Rivaroxaban—ABCB1—brain—alcohol dependence	0.000222	0.00554	CbGeAlD
Rivaroxaban—CYP3A5—Biological oxidations—CYP2E1—alcohol dependence	0.000221	0.00174	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000218	0.00172	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000208	0.00164	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GGT1—alcohol dependence	0.000203	0.0016	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.0002	0.00157	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000194	0.00152	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MAOB—alcohol dependence	0.000193	0.00152	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000183	0.00144	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—MAOA—alcohol dependence	0.000182	0.00143	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALDH2—alcohol dependence	0.000164	0.00129	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000159	0.00125	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000158	0.00124	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000151	0.00119	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GOT2—alcohol dependence	0.00014	0.0011	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—POMC—alcohol dependence	0.000139	0.00109	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP2E1—alcohol dependence	0.000131	0.00103	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000129	0.00101	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000128	0.00101	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADH6—alcohol dependence	0.000128	0.00101	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000128	0.00101	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000123	0.000972	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GOT1—alcohol dependence	0.00012	0.000949	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GGT1—alcohol dependence	0.00012	0.000949	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—POMC—alcohol dependence	0.000118	0.000933	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—EP300—alcohol dependence	0.000117	0.00092	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MAOA—alcohol dependence	0.000108	0.000851	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADH1A—alcohol dependence	0.000106	0.000834	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000105	0.000826	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000105	0.000825	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000104	0.000817	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000103	0.00081	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000101	0.000799	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADH6—alcohol dependence	9.64e-05	0.00076	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GGT1—alcohol dependence	9.44e-05	0.000744	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADH4—alcohol dependence	9e-05	0.00071	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—MAOA—alcohol dependence	8.46e-05	0.000666	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADH1A—alcohol dependence	7.99e-05	0.00063	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADH7—alcohol dependence	7.66e-05	0.000603	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GGT2—alcohol dependence	7.34e-05	0.000578	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—POMC—alcohol dependence	7.03e-05	0.000554	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADH4—alcohol dependence	6.79e-05	0.000535	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADH1B—alcohol dependence	6.71e-05	0.000529	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADH6—alcohol dependence	5.94e-05	0.000468	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	5.94e-05	0.000468	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADH7—alcohol dependence	5.78e-05	0.000455	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MAOB—alcohol dependence	5.56e-05	0.000438	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GGT2—alcohol dependence	5.54e-05	0.000436	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—POMC—alcohol dependence	5.51e-05	0.000434	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	5.45e-05	0.00043	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADH1B—alcohol dependence	5.07e-05	0.000399	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.92e-05	0.000388	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	4.91e-05	0.000387	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDH2—alcohol dependence	4.73e-05	0.000373	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—EP300—alcohol dependence	4.66e-05	0.000367	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MAOB—alcohol dependence	4.2e-05	0.000331	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADH4—alcohol dependence	4.19e-05	0.00033	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT2—alcohol dependence	4.02e-05	0.000317	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2E1—alcohol dependence	3.78e-05	0.000298	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH2—alcohol dependence	3.57e-05	0.000281	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADH7—alcohol dependence	3.56e-05	0.00028	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GGT1—alcohol dependence	3.47e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT1—alcohol dependence	3.47e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GGT2—alcohol dependence	3.41e-05	0.000269	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.12e-05	0.000246	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MAOA—alcohol dependence	3.11e-05	0.000245	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT2—alcohol dependence	3.04e-05	0.000239	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2E1—alcohol dependence	2.85e-05	0.000225	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT1—alcohol dependence	2.62e-05	0.000206	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GGT1—alcohol dependence	2.62e-05	0.000206	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MAOB—alcohol dependence	2.59e-05	0.000204	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MAOA—alcohol dependence	2.35e-05	0.000185	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.2e-05	0.000173	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—POMC—alcohol dependence	2.03e-05	0.00016	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT2—alcohol dependence	1.87e-05	0.000147	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.76e-05	0.000139	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT1—alcohol dependence	1.61e-05	0.000127	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GGT1—alcohol dependence	1.61e-05	0.000127	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—POMC—alcohol dependence	1.53e-05	0.00012	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MAOA—alcohol dependence	1.45e-05	0.000114	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—EP300—alcohol dependence	1.34e-05	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—EP300—alcohol dependence	1.01e-05	7.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—POMC—alcohol dependence	9.42e-06	7.42e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—EP300—alcohol dependence	6.25e-06	4.92e-05	CbGpPWpGaD
